日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trial

一项随机临床研究比较了曲贝替定联合区域性热疗与单用曲贝替定治疗晚期软组织肉瘤患者的疗效：HyperTET，一项德国跨学科肉瘤组试验

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2026.106921
Schuebbe, G-E; Xu, Y; Lindner, L H; Di Gioia, D; Abdel-Rahman, S; Kunz, W G; Roshchyna, T; Fenderle, R; Bücklein, V; Reichardt, P; Pink, D; Flörcken, A; Ott, O; Fietkau, R; Kampmann, E; von Bergwelt-Baildon, M; Kasper, B; Issels, R
发表日期：2026
文献求助 收藏

Adding checkpoint inhibitors to first-line chemotherapy for NUT carcinoma patients

在NUT癌患者的一线化疗中加入免疫检查点抑制剂

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-024-00768-7
Haebe, Sarah; Schuebbe, Gesa; Jurmeister, Philipp; von Bergwelt-Baildon, Michael; Westphalen, C Benedikt; Lauer, Ulrich M; Kunz, Wolfgang G; Subklewe, Marion; Weigert, Oliver
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma

异环磷酰胺、卡铂和依托泊苷（ICE）联合区域性热疗作为局部晚期非转移性和转移性软组织肉瘤患者的挽救治疗

期刊:Sarcoma
影响因子:
doi:10.1155/2020/6901678
Bücklein, Veit; Limmroth, Christina; Kampmann, Eric; Schuebbe, Gesa; Issels, Rolf; Roeder, Falk; Angele, Martin; Dürr, Hans Roland; Knösel, Thomas; Abdel-Rahman, Sultan; Di Gioia, Dorit; Lindner, Lars H
发表日期：2020
文献求助 收藏

Advances in cancer immunotherapy 2019 - latest trends

2019年癌症免疫疗法进展——最新趋势

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-019-1266-0
Kruger, Stephan; Ilmer, Matthias; Kobold, Sebastian; Cadilha, Bruno L; Endres, Stefan; Ormanns, Steffen; Schuebbe, Gesa; Renz, Bernhard W; D'Haese, Jan G; Schloesser, Hans; Heinemann, Volker; Subklewe, Marion; Boeck, Stefan; Werner, Jens; von Bergwelt-Baildon, Michael
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2019
文献求助 收藏